Bioservices (CDMO)

Expertise and Infrastructure Ready to Go to Work for You

For biopharma innovators tackling the most serious health threats and rare diseases, Emergent has the scientific and regulatory compliance experience, development and manufacturing resources, and efficient technology transfer capabilities to deliver the urgency, acuity, and scalability required to bring lifesaving and life-enhancing products to market.

Emergent’s site in Winnipeg, MB, Canada offers unique and specialized services for drug substance and drug product manufacturing and has decades of experience developing and manufacturing preclinical to commercial biotherapeutic products for biotech and pharma companies. Our clients can leverage our unique capabilities, infrastructure, and extensive scientific and regulatory expertise to support their complex cGMP manufacturing programs.

Our CDMO services include:

  • Process Development, Optimization, and Scale Up

    From process optimization, tech transfer, and scale-up, to product characterization, including formulation development and analytical services, Emergent has the capabilities and expertise to help your scientific discovery advance to its next key milestone and beyond.

  • Analytical Development and Testing Services

    Designed to provide the customized and phase-appropriate testing and support needed to meet the specific requirements of your molecule during each stage of development through commercialization.

  • Drug Substance Manufacturing

    Center of Excellence in Plasma Proteins

    • Flexible manufacturing suites for clinical to commercial manufacturing of plasma-derived therapies & other complex biological products
      • Polyclonal antibodies (Hyperimmune – up to 1200L)
      • Therapeutic proteins
  • Aseptic Fill/Finish Manufacturing

    Emergent’s Winnipeg site is equipped with a state-of-the-art Cytiva SA25 aseptic filling workcell, a gloveless robotic isolator-based filling line ideal for small to mid-scale clinical and commercial batch sizes for high-value sterile injectables.

    • Capable of filling Vials (2R – 50R), Syringes (.5mL – 10mL), and Cartridges
    • In-house inspection, labeling, and packaging solutions

Interested in discussing a potential project with Emergent?

Contact Us

Commitment to Quality & Commercial Compliance

As an experienced and attentive CDMO partner, we are committed to a regulatory-compliant and robust quality system within our network. Drawing on 25 years of developing, manufacturing, and delivering our own biotherapeutic and vaccine products to combat public health threats and infectious diseases, we have the regulatory compliance experience and knowledge required to bring life-saving, life-extending products to market. 

Regardless of your initial program goal, our goal remains the same: Provide responsive regulatory compliance support and high-quality services for our customers.

Learn more about Emergent’s approach to quality and compliance

This website uses cookies. This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Notice and Terms of Use.